Thursday, September 25, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Tesla Shares Poised for Rally as UBS Raises Delivery Forecast

Felix Baarz by Felix Baarz
September 24, 2025
in Analysis, Automotive & E-Mobility, Nasdaq
0
Tesla Stock
0
SHARES
12
VIEWS
Share on FacebookShare on Twitter

Tesla has received unexpected support from one of the world’s leading investment banks, UBS, which has significantly upgraded its third-quarter delivery projections for the electric vehicle manufacturer. This revised outlook could provide substantial momentum for the company’s stock price, though questions remain about whether this optimism extends beyond temporary tax incentives.

Revised Estimates Signal Strong Quarterly Performance

Market experts at UBS have increased their delivery forecast to 475,000 vehicles for the current quarter, representing a substantial jump from their previous estimate of 431,000 units. This new figure stands approximately 8% above Wall Street’s consensus expectations and would mark a 24% increase compared to the previous quarter’s performance.

The bank attributes this positive revision primarily to unexpectedly robust performance in the United States market. UBS researchers suggest that buyers are rushing to capitalize on the expiring $7,500 federal tax credit, potentially driving quarterly figures to their highest level since mid-2023, if not establishing a new record entirely.

Chinese Market Shows Renewed Strength

Beyond the U.S. market, Tesla is experiencing encouraging developments in the critical Chinese marketplace. Recent data indicates that 17,300 new Tesla vehicles were registered during the third week of September, reflecting a 12.7% weekly increase and reaching the highest level in twelve weeks.

Should investors sell immediately? Or is it worth buying Tesla?

Additional context from the Chinese market includes:
* Deutsche Bank projections anticipating approximately 72,000 total September deliveries in China
* This would represent a monthly increase of roughly 27%
* The newly introduced six-seater Model Y L appears to be a significant growth driver

Divergent Analyst Views Highlight Market Uncertainty

Despite these positive indicators, Tesla’s valuation remains highly contested among financial institutions. While UBS has raised its delivery forecast, the bank maintains its “sell” recommendation with a price target of $215, suggesting substantial potential downside.

This contrasts sharply with Piper Sandler’s recent assessment, which elevated its price target to $500. The majority of market analysts, however, maintain “hold” positions on the stock. This extreme divergence in professional opinion underscores fundamental questions about Tesla’s current valuation: has the stock become overextended following recent gains, or is this merely the beginning of a sustained upward trajectory?

Ad

Tesla Stock: Buy or Sell?! New Tesla Analysis from September 25 delivers the answer:

The latest Tesla figures speak for themselves: Urgent action needed for Tesla investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from September 25.

Tesla: Buy or sell? Read more here...

Tags: Tesla
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

Take-Two Stock
Analysis

Take-Two Shares Face Pressure Ahead of Earnings Report

September 25, 2025
ImmunityBio Stock
Analysis

ImmunityBio’s Clinical Breakthroughs Fuel Investor Optimism

September 25, 2025
Baidu Stock
AI & Quantum Computing

Baidu’s Dual Engine: AI and Autonomous Driving Fuel Growth Trajectory

September 25, 2025
Next Post
Vici Properties Stock

Vici Properties: Market Hesitation Meets Strategic Expansion

Evolent Health Stock

Evolent Health Sells Primary Care Division in Strategic Shift

WiMi Hologram Cloud Stock

WiMi's Quantum Computing Breakthrough Sparks Sustained Stock Rally

Recommended

Adobe Stock

Adobe’s AI Ambitions Face Investor Scrutiny as Shares Slide

3 weeks ago
Neurotech

Analyst Provides Neutral Rating and Increased Price Target for Everbridge

2 years ago
OHI stock news

Analyst Ben Haynor Recommends Buying Shares of Profound Medical with Revised Price Target

2 years ago
Finance_ People trading stocks

Interpreting Unusual Options Activity in the Financial Market

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD Apple ASML BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir PayPal Pepsi Red Cat Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla TSLA Unitedhealth Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

ImmunityBio’s Clinical Breakthroughs Fuel Investor Optimism

Baidu’s Dual Engine: AI and Autonomous Driving Fuel Growth Trajectory

Vertiv Shares Face Pressure as Microsoft’s Cooling Tech Sparks Investor Concerns

Texas Instruments: A Tale of Strong Dividends and Market Uncertainty

BigBear.ai Shares Surge on Major US Navy AI Partnership

Snowflake’s Leadership and Strategy Shift: A Tale of Two Narratives

Trending

Eli Lilly Stock
Earnings

Eli Lilly Bets Billions on Unapproved Weight-Loss Pill with Major Texas Facility

by Robert Sasse
September 25, 2025
0

Eli Lilly is making an unprecedented $6.5 billion wager on a single facility in Texas, dedicated to...

Take-Two Stock

Take-Two Shares Face Pressure Ahead of Earnings Report

September 25, 2025
Airbus Stock

Airbus Helicopter Division Secures Major Contracts Amid Industry Challenges

September 25, 2025
ImmunityBio Stock

ImmunityBio’s Clinical Breakthroughs Fuel Investor Optimism

September 25, 2025
Baidu Stock

Baidu’s Dual Engine: AI and Autonomous Driving Fuel Growth Trajectory

September 25, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Eli Lilly Bets Billions on Unapproved Weight-Loss Pill with Major Texas Facility
  • Take-Two Shares Face Pressure Ahead of Earnings Report
  • Airbus Helicopter Division Secures Major Contracts Amid Industry Challenges

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com